CDRH’s Shuren Signals More Guidance, Enhanced Pre-Market Payer Role

CDRH Director Jeffrey Shuren details plans for new guidance documents and process changes at the device center, focused on IDE reviews, clinical testing requirements and pre-submission interactions with payers based on recommendations from the center’s entrepreneurs-in-residence program.